European HealthTech this week is characterised by AI‑heavy care models preparing for the EU AI Act, continued investor focus on preventive and platform plays, and early‑stage funding/grant activity positioning startups for 2026–27 scale‑up. European MedTech this week is dominated by regulatory moves in Brussels, tightening timelines ahead of the 2026 MDR/IVDR and EUDAMED deadlines, alongside positioning by industry and investors for an “industrial maturity” phase rather than

The "70% Paradox" represents a critical convergence of infrastructure barriers threatening healthcare's AI transformation: 70% of doctors identify poor electronic patient record (EPR) integration as the primary obstacle to AI adoption, while approximately 80% of healthcare data remains locked in unstructured formats that AI systems struggle to leverage effectively. This paradox exposes a fundamental misalignment between healthcare's data infrastructure and the requirements of

The announcement of Epic’s general release of its AI Charting suite in February 2026 marks a definitive shift in the digital health infrastructure of the modern era. This deployment, unveiled during the "Winter Cool Stuff Ahead" customer event, signifies more than a mere feature update; it represents the consolidation of ambient sensing, generative large language models, and deep electronic health record integration into a unified clinical assistant framework.

The rise and subsequent decline of IBM Watson Health represents a seminal case study in the intersection of legacy industrial computing, the aggressive financialization of medical data, and the premature deployment of narrow artificial intelligence in high-stakes clinical environments. Once heralded as the panacea for the complexities of modern oncology, Watson Health was positioned by IBM leadership as a "moonshot" capable of democratizing elite medical expertise through the

The designation of Scotland’s life sciences and healthtech sector as a "sleeping giant" is a reflection of the profound dichotomy between the nation’s latent potential and its current commercial realisation. Possessing a healthcare system with a unified patient identifier, a stable and research-engaged population, and a legacy of medical innovation that spans centuries, the infrastructure for a global powerhouse is undeniably present. However, as of early 2026, the sector’s t

The Finnish health technology and medical technology sector has, by the first quarter of 2026, successfully navigated a transformation from a fragmented landscape of high-potential startups into a unified, mature industrial powerhouse. This evolution is not merely a quantitative increase in export values or corporate valuations but represents a fundamental shift in the "industrial logic" of the ecosystem.

European HealthTech this week is dominated by regulatory fine‑tuning around AI in devices, fresh EU‑level funding calls, and continued capital and grant focus on AI‑enabled care delivery and data platforms. European MedTech this week is being shaped by MDR/IVDR simplification moves, the hardening EUDAMED timetable, and EU‑level initiatives (including the Biotech Act and IHI Call 12) that favour data‑rich,

The architectural landscape of global healthcare informatics is currently undergoing a fundamental realignment, shifting from a provider-centric, siloed model of data management toward a decentralized, patient-mediated paradigm. This transition is predicated on the maturation of the Fast Healthcare Interoperability Resources (FHIR) standard, specifically version R4, which has ascended as the global benchmark for health data exchange. By leveraging these standards, consumer te

As the United States economy navigates the tumultuous waters of 2026, the prevailing macroeconomic narrative is dominated by the volatility and valuation extremes of the artificial intelligence sector. With market capitalisation concentration in the "Magnificent Seven" reaching historic deviations from mean trends, and capital expenditure on data center infrastructure projected to hit trillions, market observers and economists alike warn of a correction analogous to the 2000

The European healthcare technology landscape has reached a profound inflection point in 2026, transitioning from a period of speculative, venture-subsidised fragmentation into a disciplined era defined by industrial maturity and strategic consolidation. This systemic shift is most visible in the rapid maturation of Ambient Voice Technology (AVT), a subset of artificial intelligence designed to ambiently capture clinical consultations and automate documentation.

The global healthcare sector stands at a critical juncture, navigating a technological inflection point that is as transformative as the digitisation of health records, yet far more perilous due to its clandestine nature. We are witnessing the rapid, unregulated, and often invisible integration of artificial intelligence (AI) into the core workflows of medicine—a phenomenon collectively termed "Shadow AI." Unlike the Shadow IT of the past, which largely concerned the unauthor

European HealthTech this week is being shaped by fresh EU-level funding calls for digital health and AI, tightening but slightly simplified device and AI regulation, and continued emphasis on compliance‑driven M&A and scaling of AI decision‑support. Capital is available but flowing selectively into data‑rich platforms, cross‑border care models, and AI‑enabled diagnostics that can navigate the emerging AI Act / MDR / HTA stack.

European HealthTech this week is characterised by EU‑level AI and data initiatives moving into implementation, fresh and upcoming funding calls for digital health innovators, and a continued tilt toward AI‑driven automation and consolidation plays as 2026 opens.​ European MedTech this week is shaped by three themes: MDR/IVDR simplification and EUDAMED timing, new guidance for Notified Bodies, and a steady drumbeat of innovation and capital around robotics, neuro and data‑rich

Nelson Advisors 2026 Video of Market Predictions, Insights and Observations in HealthTech, MedTech and Digital Health.

The first week of December 2025 was defined by two major themes: the domination of RSNA 2025 by European imaging giants and a landmark public private investment partnership to fuel the continent's life sciences sector. The first week of December 2025 highlighted a pivotal shift in European HealthTech regulation, with the European Commission moving to unlock patient data for AI training, a long-awaited reform for the sector. In the UK, the NHS continued its digital integratio